MP
PFE icon

McDonald Partners’s Pfizer PFE Stock Holding History

McDonald Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.44M Sell
101,152
-1,400
-1% -$36.6K 0.59% 53
2026
Q1 		$2.88M Buy
102,552
+7,726
+8% +$206K 0.68% 46
2025
Q4 		$2.36M Buy
94,826
+20,719
+28% +$522K 0.74% 37
2025
Q3 		$1.89M Sell
74,107
-42,689
-37% -$1.05M 0.56% 44
2025
Q2 		$2.83M Buy
116,796
+1,102
+1% +$25.7K 0.68% 36
2025
Q1 		$2.93M Buy
115,694
+5,398
+5% +$141K 0.76% 35
2024
Q4 		$2.93M Buy
110,296
+9,963
+10% +$270K 0.75% 37
2024
Q3 		$2.9M Buy
100,333
+9,462
+10% +$276K 0.73% 38
2024
Q2 		$2.54M Buy
90,871
+23,113
+34% +$636K 0.68% 39
2024
Q1 		$1.88M Buy
67,758
+17,939
+36% +$498K 0.52% 54
2023
Q4 		$1.43M Sell
49,819
-29,641
-37% -$896K 0.43% 72
2023
Q3 		$2.64M Sell
79,460
-6,656
-8% -$235K 0.86% 34
2023
Q2 		$3.16M Sell
86,116
-2,192
-2% -$85.3K 0.97% 26
2023
Q1 		$3.6M Sell
88,308
-5,926
-6% -$256K 1.17% 16
2022
Q4 		$4.83M Sell
94,234
-663
-0.7% -$31.8K 1.65% 11
2022
Q3 		$4.15M Sell
94,897
-27,163
-22% -$1.32M 1.58% 13
2022
Q2 		$6.4M Sell
122,060
-1,304
-1% -$66.5K 1.63% 7
2022
Q1 		$6.39M Buy
123,364
+123,311
+232,662% +$6.4M 1.39% 8
2021
Q4 		$3.13K Sell
53
-120,556
-100% -$5.97M ﹤0.01% 286
2021
Q3 		$5.19M Sell
120,609
-1,282
-1% -$56.8K 1.22% 15
2021
Q2 		$4.77M Buy
121,891
+4,330
+4% +$168K 1.13% 17
2021
Q1 		$4.26M Sell
117,561
-1,384
-1% -$49.1K 1.09% 16
2020
Q4 		$4.38M Buy
+118,945
New +$4.36M 1.23% 16

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

McDonald Partners's PFE Position: Q2 2026 in Review

McDonald Partners reduced its Pfizer (PFE) stake by 1.4% in Q2 2026, selling an estimated $36.6K and leaving 101,152 shares worth $2.44M. The position accounts for 0.59% of the portfolio, ranked #53.

McDonald Partners first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $6.4M in Q2 2022. 2,826 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • McDonald Partners held 101,152 shares of Pfizer worth $2.44M as of Q2 2026.
  • McDonald Partners sold 1,400 Pfizer shares in Q2 2026, an estimated $36.6K.
  • Pfizer made up 0.59% of McDonald Partners's portfolio in Q2 2026, its #53 holding.
  • McDonald Partners first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • McDonald Partners's Pfizer position peaked at $6.4M in Q2 2022.
  • 2,826 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on McDonald Partners's 13F filing for Q2 2026, filed 28 Jul 2026.